DR. KATRIEN BOLLEN
ActiveDR. KATRIEN BOLLEN has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €100k and a net result of €17k. Equity is growing by ~48% per year across the filed fiscal years. Its solvency ranks better than 29% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
78
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability76▼-23
Solvency60▼-1
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.22 against 1.12 in 2024; short-term debt: 32.1% and cash: 29.4% of total assets), and 64.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
35.3%
Return on assets
6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-04-2026, 105 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
105 d early
2024
77 d early
2023
97 d early
2022
101 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€100k=
2024 · €100k
2022: €6k
2023: €34k
2024: €100k
2022 → 2025
Total assets
€283k▲ 2.6%
2024 · €275k
2022: €66k
2023: €82k
2024: €275k
2022 → 2025
Net result
€17k▼ 74.1%
2024 · €66k
2022: €5k
2023: €28k
2024: €66k
2022 → 2025
Working capital
€20k▲ 121%
2024 · €9k
2022: €-17k
2023: €-17
2024: €9k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€6k-€34k▲ 452%€100k▲ 194%€100k=
Operating result€8k-€41k▲ 400%€87k▲ 115%€29k▼ 67.0%
Net result€5k-€28k▲ 498%€66k▲ 137%€17k▼ 74.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 67% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €283k
Fixed assets
€171k▼ 8.7%
Current assets
€111k▲ 26.7%
Equity and liabilities €283k
Equity
€100k=
Debt
€183k▲ 4.0%
The debt ratio rises from 63.8% to 64.7%. Debt is higher.
Key figures and ratios
EBITDA
€52k▼
2024 · €101k
Cash flow
€41k▼
2024 · €80k
Solvency
35.3%▼
2024 · 36.2%
Current ratio
1.22▲
2024 · 1.12
Quick ratio
1.06▲
2024 · 0.96
Debt / equity
1.83▲
2024 · 1.76
ROE
17.1%▼
2024 · 66.0%
ROA
6.0%▼
2024 · 23.9%
Interest coverage
12.71▼
2024 · 66.56
Debt
€183k▲
2024 · €176k
Debt ≤ 1 year
€91k▲
2024 · €78k
Debt > 1 year
€92k▼
2024 · €96k
Income taxes
€8k▼
2024 · €23k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€275k€283k▲
Fixed assets21/28€188k€171k▼
Tangible fixed assets22/27€188k€171k▼
Land and buildings22€165k€149k▼
Plant, machinery and equipment23€18k€15k▼
Furniture and vehicles24€5k€8k▲
Current assets29/58€88k€111k▲
Stocks and contracts in progress3€12k€15k▲
Stocks30/36€12k€15k▲
Amounts receivable within one year40/41€7k€10k▲
Trade receivables40€2k€4k▲
Other amounts receivable41€5k€6k▲
Cash at bank and in hand54/58€64k€83k▲
Deferred charges and accrued income490/1€5k€2k▼
Equity and liabilities
Total equity and liabilities10/49€275k€283k▲
Equity10/15€100k€100k=
Contributions10/11€2k€2k=
Reserves13€98k€98k=
Distributable reserves133€98k€98k=
Profit (loss) carried forward14-€18
Amounts payable17/49€176k€183k▲
Amounts payable after more than one year17€96k€92k▼
Financial debts170/4€96k€92k▼
Amounts payable within one year42/48€78k€91k▲
Current portion of amounts payable after more than one year42€3k€4k▲
Trade debts44€3k€3k▲
Suppliers440/4€3k€3k▲
Taxes, remuneration and social security45€36k€37k▲
Taxes450/3€36k€37k▲
Other amounts payable47/48€36k€47k▲
Accrued charges and deferred income492/3€2k-
Income statement
Code20242025
Non-recurring operating income76A€1k€1k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14k€24k▲
Other operating charges640/8€5k€1k▼
Gross operating margin9900€106k€54k▼
Operating profit (loss)9901€87k€29k▼
Financial income75/76B€3k€0▼
Recurring financial income75€1€0▼
Non-recurring financial income76B€3k-
Financial charges65/66B€2k€4k▲
Recurring financial charges65€2k€4k▲
Profit (loss) for the period before taxes9903€89k€25k▼
Income taxes67/77€23k€8k▼
Profit (loss) for the period9904€66k€17k▼
Profit (loss) for the period to be appropriated9905€66k€17k▼
Appropriation of the result
Profit (loss) to be appropriated9906€66k€17k▼
Transfer to equity691/2€66k-
To other reserves6921€66k-
Profit to be distributed694/7-€17k
Return on contributions (dividend)694-€17k
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
17-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
15-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €66k ▲137%
Operating result €87k, net result €66k, both a record.
25-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
21-04
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Maasmechelen · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Leopoldstraat(M) 203630 MaasmechelenGround area
2,717 m²
Building footprint
397 m²
Volume, LiDAR
2,286 m³
2 parcels, Flanders · tallest building 12.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Cura Suì Clinic
since 20222.325.191.948
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73048C0160/00E000 | Flanders | 2,084 m² | 1 · 288 m² | 8.6 m · 2 fl. |
| 73048C0275/00B000 | Flanders | 633 m² | 1 · 109 m² | 12.3 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. Evelien Byloos
BE 0673.492.081
Haacht · Eq €100k
Dr. Alkarouchi
BE 1004.361.556
Antwerpen · Eq €100k
Dr. Lize Schroé
BE 0704.729.051
Holsbeek · Eq €100k
Centre Médical des Marêts
BE 0846.072.305
Seraing · Eq €100k
Dr. Charlotte Celis
BE 0769.542.075
Bornem · Eq €100k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,269 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-12-2021
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.